Abbott India · NSE: ABBOTINDIA · BSE: 500488
Q4 FY21 results · Jan–Mar 2021
Abbott India reported revenue from operations of ₹1,095.54 crore (up 14.0% from Q4 FY20) and net profit of ₹152.47 crore (up 37.4% from Q4 FY20) for Q4 FY21 (Jan–Mar 2021), on a standalone basis.
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,095.54 | 961.20 | +14.0% | 1,095.37 | +0.0% |
| Other income | 16.20 | 28.13 | −42.4% | 15.01 | +7.9% |
| Total income | 1,111.74 | 989.33 | +12.4% | 1,110.38 | +0.1% |
| Profit before tax | 201.88 | 148.93 | +35.6% | 237.88 | −15.1% |
| Net profit for the period | 152.47 | 110.97 | +37.4% | 177.14 | −13.9% |
| EPS, basic (₹) | 71.75 | 52.22 | +37.4% | 83.36 | −13.9% |
| Net margin (%) | 13.9 | 11.5 | 16.2 |
Standalone
- Filed with BSE
- 18 May 2021, 15:17 IST
- Board meeting
- 18 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE